2-methoxy-4-{[(prop-2-en-1-yl)amino]methyl}phenol, 95.0%, 1g

5-BROMO-N4-METHYL-PYRIDINE-3,4-DIAMINE, 95.0%, 250mg

(R)-2-(2-Phenylacetamido)hexanedioic acid, 100mg

2-Amino-5-bromo-4,6-dimethylpyridine, 95.0%, 25g

Butyltriphenylphosphonium bromide, 95.0%, 500g

Heptano (isómeros), mínimo 98,5 %, para síntesis, 10 l, whitbl.

(2S,5S)-1-[2-(1,3-Dioxolan-2-yl)phenyl]-2,5-dimethylphospholane, 97%, 250mg

1-(Quinoxalin-2-yl)ethanone, 97.0%, 250mg

ethyl 6-methyl-4-phenyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 5g

(2R,5S)-1-Boc-2,5-dimethylpiperazine hydrochloride, 95.0%, 5g

Ftalocianina de cobre, mínimo 98 %, 25 g, envase de vidrio

6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazole-3-carboxylic acid, 95.0%, 5g

Methyl-(2-phenoxy-ethyl)-amine, 95.0%, 1g